Search
for

    Sort by

    Research 901–930 of 1000+

    1. Az alopecia areata kezelésében alkalmazott baricitinib hatásosságának és biztonságosságának retrospektív vizsgálata = Efficacy and safety of baricitinib treatment in alopecia areata:a retrospective analysis Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) · 2025
    2. Randomized Controlled Trial Study to Evaluate the Efficacy of Combination Therapy with Diphenylcyclopropenone and Platelet-Rich Plasmain Alopecia Areaata International Journal of Trichology · 2025
    3. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    4. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    5. Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients Acta Dermatovenerologica Alpina Pannonica et Adriatica · 2025
    6. Evaluation of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, CRP and ESR with disease severity in patients with alopecia areata International Journal of Dermatology Research · 2025
    7. Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    8. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    9. Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year Journal of the European Academy of Dermatology and Venereology · 2024
    10. 319 Novel Circulating Natural Killer Cell Subset as Biomarkers in Alopecia Areata Progression Journal of Investigative Dermatology · 2024
    11. Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials SKIN The Journal of Cutaneous Medicine · 2024
    12. Long‐term outcomes of intravenous corticosteroid pulse therapy for rapidly progressive alopecia areata: A single‐center retrospective analysis of 106 cases and usefulness evaluation of a scoring system originally designed for half‐year efficacy prediction for extended periods The Journal of Dermatology · 2024
    13. Comparison of efficacy of intralesional triamcinolone versus 308nm Excimer laser in the treatment of localized alopecia areata Journal of Pakistan Association of Dermatologists · 2024
    14. COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF TOPICAL METHOTREXATE WITH TRETINOIN VERSUS BETAMETHASONE WITH TRETINOIN IN PATIENTS OF ALOPECIA AREATA: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY Asian Journal of Pharmaceutical and Clinical Research · 2024
    15. Study of Skin Microbiome in Patients with Alopecia Areata: Case Control Study QJM · 2024
    16. Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study Journal of Cosmetic Dermatology · 2024
    17. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study Journal of the European Academy of Dermatology and Venereology · 2024
    18. 54440 An open label trial evaluating the use of microneedling in hair loss Journal of the American Academy of Dermatology · 2024
    19. 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    20. 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    21. 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2 Journal of the American Academy of Dermatology · 2024
    22. 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata British Journal of Dermatology · 2024
    23. Efficacy of modern methods for assessing the severity of alopecia areata Medical alphabet · 2024
    24. Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint) 2024
    25. Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata Indian Dermatology Online Journal · 2024
    26. Efficacy of Intralesional Vitamin D in the Treatment of Alopecia Areata Using Dermoscopy before and after Treatment Zagazig University Medical Journal · 2024
    27. Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials JEADV Clinical Practice · 2024
    28. Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches Cureus · 2024
    29. Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients Australasian Journal of Dermatology · 2024
    30. Role of platelet rich plasma therapy in the treatment of alopecia areata and atrophic acne scars IP Indian journal of clinical and experimental dermatology · 2024